Suppr超能文献

脂多糖清除、细菌清除和全身炎症反应是由脓毒症期间 TLR4 的细胞类型特异性功能调节的。

Lipopolysaccharide clearance, bacterial clearance, and systemic inflammatory responses are regulated by cell type-specific functions of TLR4 during sepsis.

机构信息

Department of Surgery, University of Pittsburgh, Pittsburgh, PA 15213, USA.

出版信息

J Immunol. 2013 May 15;190(10):5152-60. doi: 10.4049/jimmunol.1300496. Epub 2013 Apr 5.

Abstract

The morbidity associated with bacterial sepsis is the result of host immune responses to pathogens, which are dependent on pathogen recognition by pattern recognition receptors, such as TLR4. TLR4 is expressed on a range of cell types, yet the mechanisms by which cell-specific functions of TLR4 lead to an integrated sepsis response are poorly understood. To address this, we generated mice in which TLR4 was specifically deleted from myeloid cells (LysMTLR4KO) or hepatocytes (HCTLR4KO) and then determined survival, bacterial counts, host inflammatory responses, and organ injury in a model of cecal ligation and puncture (CLP), with or without antibiotics. LysM-TLR4 was required for phagocytosis and efficient bacterial clearance in the absence of antibiotics. Survival, the magnitude of the systemic and local inflammatory responses, and liver damage were associated with bacterial levels. HCTLR4 was required for efficient LPS clearance from the circulation, and deletion of HCTLR4 was associated with enhanced macrophage phagocytosis, lower bacterial levels, and improved survival in CLP without antibiotics. Antibiotic administration during CLP revealed an important role for hepatocyte LPS clearance in limiting sepsis-induced inflammation and organ injury. Our work defines cell type-selective roles for TLR4 in coordinating complex immune responses to bacterial sepsis and suggests that future strategies for modulating microbial molecule recognition should account for varying roles of pattern recognition receptors in multiple cell populations.

摘要

与细菌败血症相关的发病率是宿主对病原体的免疫反应的结果,而这些反应依赖于模式识别受体(如 TLR4)对病原体的识别。TLR4 表达于多种细胞类型,但 TLR4 的细胞特异性功能如何导致整合的败血症反应的机制仍不清楚。为了解决这个问题,我们生成了骨髓细胞(LysM-TLR4KO)或肝细胞(HCTLR4KO)特异性缺失 TLR4 的小鼠,然后在盲肠结扎和穿刺(CLP)模型中确定了生存、细菌计数、宿主炎症反应和器官损伤,同时使用或不使用抗生素。在没有抗生素的情况下,LysM-TLR4 对于吞噬作用和有效的细菌清除是必需的。生存、全身和局部炎症反应的程度以及肝损伤与细菌水平有关。HCTLR4 对于从循环中清除 LPS 是必需的,而 HCTLR4 的缺失与巨噬细胞吞噬作用增强、细菌水平降低以及在没有抗生素的 CLP 中生存率提高有关。CLP 期间给予抗生素揭示了肝细胞 LPS 清除在限制败血症引起的炎症和器官损伤中的重要作用。我们的工作定义了 TLR4 在协调对细菌性败血症的复杂免疫反应中的细胞类型选择性作用,并表明未来调节微生物分子识别的策略应该考虑到模式识别受体在多种细胞群体中的不同作用。

相似文献

2
Suppression of PTRF alleviates the polymicrobial sepsis induced by cecal ligation and puncture in mice.
J Infect Dis. 2013 Dec 1;208(11):1803-12. doi: 10.1093/infdis/jit364. Epub 2013 Aug 1.
3
Toll-like receptor 4 deficiency increases resistance in sepsis-induced immune dysfunction.
Int Immunopharmacol. 2018 Jan;54:169-176. doi: 10.1016/j.intimp.2017.11.006. Epub 2017 Nov 14.
5
Enhancing Nrf2 pathway by disruption of Keap1 in myeloid leukocytes protects against sepsis.
Am J Respir Crit Care Med. 2011 Oct 15;184(8):928-38. doi: 10.1164/rccm.201102-0271OC. Epub 2011 Jul 28.
6
Scavenger Receptor BI Protects against Septic Death through Its Role in Modulating Inflammatory Response.
J Biol Chem. 2009 Jul 24;284(30):19826-34. doi: 10.1074/jbc.M109.020933. Epub 2009 Jun 2.
7
Toll-like receptor 4 plays a role in macrophage phagocytosis during peritoneal sepsis.
J Pediatr Surg. 2007 Jun;42(6):927-32; discussion 933. doi: 10.1016/j.jpedsurg.2007.01.023.
8
Adoptive transfer of CD34(+) cells during murine sepsis rebalances macrophage lipopolysaccharide responses.
Immunol Cell Biol. 2012 Nov;90(10):925-34. doi: 10.1038/icb.2012.32. Epub 2012 Jun 26.
9
Poly(I:C) Priming Exacerbates Cecal Ligation and Puncture-Induced Polymicrobial Sepsis in Mice.
Inflammation. 2018 Feb;41(1):328-336. doi: 10.1007/s10753-017-0690-6.
10
Triggering receptor expressed on myeloid cells-2 protects against polymicrobial sepsis by enhancing bacterial clearance.
Am J Respir Crit Care Med. 2013 Jul 15;188(2):201-12. doi: 10.1164/rccm.201211-1967OC.

引用本文的文献

2
The Battle of LPS Clearance in Host Defense vs. Inflammatory Signaling.
Cells. 2024 Sep 21;13(18):1590. doi: 10.3390/cells13181590.
3
Compartmentalization of the inflammatory response during bacterial sepsis and severe COVID-19.
J Intensive Med. 2024 Feb 27;4(3):326-340. doi: 10.1016/j.jointm.2024.01.001. eCollection 2024 Jul.
4
Contributions of the microbiota to the systemic inflammatory response.
Microbiota Host. 2023 Feb;1(1). doi: 10.1530/mah-23-0018. Epub 2023 Dec 18.
8
The pathogenesis and potential therapeutic targets in sepsis.
MedComm (2020). 2023 Nov 20;4(6):e418. doi: 10.1002/mco2.418. eCollection 2023 Dec.
9
Advances in Mesenchymal stem cells regulating macrophage polarization and treatment of sepsis-induced liver injury.
Front Immunol. 2023 Oct 25;14:1238972. doi: 10.3389/fimmu.2023.1238972. eCollection 2023.
10
P2Y2 purinergic receptor gene deletion protects mice from bacterial endotoxin and sepsis-associated liver injury and mortality.
Am J Physiol Gastrointest Liver Physiol. 2023 Nov 1;325(5):G471-G491. doi: 10.1152/ajpgi.00090.2023. Epub 2023 Sep 12.

本文引用的文献

1
Intestinal epithelial Toll-like receptor 4 regulates goblet cell development and is required for necrotizing enterocolitis in mice.
Gastroenterology. 2012 Sep;143(3):708-718.e5. doi: 10.1053/j.gastro.2012.05.053. Epub 2012 Jul 13.
3
4
The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of MyD88 and TRIF.
J Immunol. 2012 May 1;188(9):4506-15. doi: 10.4049/jimmunol.1200202. Epub 2012 Apr 2.
5
Hepatic uptake and deacylation of the LPS in bloodborne LPS-lipoprotein complexes.
Innate Immun. 2012 Dec;18(6):825-33. doi: 10.1177/1753425912442431. Epub 2012 Mar 22.
6
Treatment of myocardial dysfunction in sepsis: the Toll-like receptor antagonist approach.
Shock. 2011 Dec;36(6):633-4. doi: 10.1097/SHK.0b013e318237a37b.
7
Current insights in sepsis: from pathogenesis to new treatment targets.
Curr Opin Crit Care. 2011 Oct;17(5):480-6. doi: 10.1097/MCC.0b013e32834a4aeb.
8
The Toll-like receptor 4 agonist monophosphoryl lipid a augments innate host resistance to systemic bacterial infection.
Infect Immun. 2011 Sep;79(9):3576-87. doi: 10.1128/IAI.00022-11. Epub 2011 Jun 6.
9
Toll-like receptor-4 antagonist eritoran tetrasodium for severe sepsis.
Expert Rev Anti Infect Ther. 2011 May;9(5):507-20. doi: 10.1586/eri.11.27.
10
Toll-like receptors in acute liver injury and regeneration.
Int Immunopharmacol. 2011 Oct;11(10):1433-41. doi: 10.1016/j.intimp.2011.04.023. Epub 2011 May 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验